email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
361 - 375
of 3615 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Innovent Collaborates with RemeGen to Test PD-1/ADC Combination for Solid Tumors
$5.00
Available
Edding Group Files for Hong Kong IPO to Support its China In-licensing Operations
$5.00
Available
Everest Medicines Reports In-licensed Candidate Effective for Rare Kidney Disease
$5.00
Available
BioCity Starts China Phase II Trial of ETA-Receptor Antagonist for Kidney Disease
$5.00
Available
WestGene Biopharma Raises $42 Million in a Series A Funding for its mRNA Portfolio
$5.00
Available
Minghui Starts Clinical Trials for Two Novel ADCs Aimed at Solid Tumor Cancers
$5.00
Available
AstraZeneca May Create New Company for China Ops and List in Hong Kong or Shanghai
$5.00
Available
Cutia Therapeutics Raises $65 Million in Hong Kong IPO for Dermatology Products
$5.00
Available
Cullgen Forms $1.9 Billion Collaboration with Astellas for Protein Degraders
$5.00
Available
Cholesgen Collaborates with AstraZeneca to Develop Hypercholesterolemia Candidates
$5.00
Available
HighField Bio to Start US Trial of Immunoliposome for Solid Tumor Cancers
$5.00
Available
Genor Biopharma’s PD-1 Drug Nixed by China Regulators for Rare Lymphoma
$5.00
Available
Simcere to Underwrite up to Eight Research Projects at Mass General Brigham
$5.00
Available
China Medical System’s Novel Nasal Spray Approved to Treat Seizures in China
$5.00
Available
Innovent’s anti-CD47/PD-L1 Bispecific Antibody Effective in Hodgkin Lymphoma
$5.00
Available